DE60112413D1 - Ssa inaktivierte salmonella impfstoffe - Google Patents

Ssa inaktivierte salmonella impfstoffe

Info

Publication number
DE60112413D1
DE60112413D1 DE60112413T DE60112413T DE60112413D1 DE 60112413 D1 DE60112413 D1 DE 60112413D1 DE 60112413 T DE60112413 T DE 60112413T DE 60112413 T DE60112413 T DE 60112413T DE 60112413 D1 DE60112413 D1 DE 60112413D1
Authority
DE
Germany
Prior art keywords
ssa
inactivated salmonella
salmonella vaccines
vaccines
inactivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60112413T
Other languages
English (en)
Other versions
DE60112413T2 (de
Inventor
E Lowery
J Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of DE60112413D1 publication Critical patent/DE60112413D1/de
Application granted granted Critical
Publication of DE60112413T2 publication Critical patent/DE60112413T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60112413T 2000-03-17 2001-03-13 Ssa inaktivierte salmonella impfstoffe Expired - Fee Related DE60112413T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19017800P 2000-03-17 2000-03-17
US190178P 2000-03-17
PCT/US2001/008042 WO2001070247A2 (en) 2000-03-17 2001-03-13 Salmonella vaccine materials and methods

Publications (2)

Publication Number Publication Date
DE60112413D1 true DE60112413D1 (de) 2005-09-08
DE60112413T2 DE60112413T2 (de) 2006-06-01

Family

ID=22700305

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112413T Expired - Fee Related DE60112413T2 (de) 2000-03-17 2001-03-13 Ssa inaktivierte salmonella impfstoffe

Country Status (17)

Country Link
US (2) US6923957B2 (de)
EP (1) EP1267899B1 (de)
JP (1) JP2003527433A (de)
AR (1) AR027680A1 (de)
AT (1) ATE300949T1 (de)
AU (2) AU2001256957B2 (de)
BR (1) BR0109322A (de)
CA (1) CA2402252A1 (de)
DE (1) DE60112413T2 (de)
DK (1) DK1267899T3 (de)
ES (1) ES2244617T3 (de)
MX (1) MXPA02008748A (de)
NZ (1) NZ521425A (de)
PE (1) PE20011180A1 (de)
PT (1) PT1267899E (de)
WO (1) WO2001070247A2 (de)
ZA (1) ZA200207002B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe
JP2006518191A (ja) * 2003-01-09 2006-08-10 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 細菌ワクチンベクターの免疫原性を強化するための組成物、方法、及びキット
CN1297315C (zh) * 2004-11-25 2007-01-31 上海交通大学 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法
CA2608636C (en) * 2005-05-17 2015-02-10 Frank Koentgen Sequential cloning system
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
MY188753A (en) * 2006-09-18 2021-12-29 Univ Arkansas Compositions and methods of enhancing immune responses
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US9125854B2 (en) * 2007-10-30 2015-09-08 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
NZ585777A (en) * 2007-11-01 2012-09-28 Univ Arkansas Compositions and methods of enhancing immune responses to eimeria
CA2703519C (en) 2007-11-09 2017-04-18 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
UA110024C2 (uk) 2010-01-21 2015-11-10 Вакцинний вектор і спосіб посилення імунної відповіді
AU2011264772B2 (en) 2010-06-09 2015-07-16 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce Campylobacter infection
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US8481052B2 (en) 2011-05-17 2013-07-09 Cj Cheiljedang Corporation Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US20150238590A1 (en) * 2012-10-22 2015-08-27 The Board Of Regents For Oklahoma State University Use of the salmonella spp type iii secretion proteins as a protective vaccination
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
ES2758759T3 (es) 2013-02-14 2020-05-06 Univ Arkansas Composiciones y métodos para potenciar las respuestas inmunitarias a eimeria o limitar la infección por eimeria
MY173901A (en) 2013-03-15 2020-02-26 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to enteric pathogens
US20170333493A1 (en) * 2014-11-11 2017-11-23 Ohio State Innovation Foundation Probiotic bacteria for the prevention and treatment of salmonella
MX2018003173A (es) * 2015-09-16 2018-05-17 Boehringer Ingelheim Vetmedica Inc Vacunas de salmonella choleraesuis-salmonella typhimurium.
EP3452069A4 (de) 2016-05-03 2020-02-12 The Board of Trustees of the University of Arkansas Hefeimpfstoffvektor mit immunstimulierenden und antigenen polypeptiden und verfahren zur verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
KR100445103B1 (ko) 1994-12-09 2004-12-04 임페리얼 컬리지 이노베이션스 리미티드 유전자의동정
AU5860599A (en) * 1998-09-04 2000-03-27 Creatogen Aktiengesellschaft Attenuated salmonella spi2 mutants as antigen carriers
NZ519477A (en) 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe

Also Published As

Publication number Publication date
ATE300949T1 (de) 2005-08-15
DK1267899T3 (da) 2005-12-12
CA2402252A1 (en) 2001-09-27
AU2001256957B2 (en) 2005-08-25
US6923957B2 (en) 2005-08-02
BR0109322A (pt) 2002-12-10
MXPA02008748A (es) 2003-02-24
WO2001070247A2 (en) 2001-09-27
JP2003527433A (ja) 2003-09-16
EP1267899A2 (de) 2003-01-02
AU5695701A (en) 2001-10-03
PE20011180A1 (es) 2001-11-15
US20040009191A1 (en) 2004-01-15
NZ521425A (en) 2004-05-28
AR027680A1 (es) 2003-04-09
EP1267899B1 (de) 2005-08-03
US20050260223A1 (en) 2005-11-24
WO2001070247A3 (en) 2002-04-18
ES2244617T3 (es) 2005-12-16
DE60112413T2 (de) 2006-06-01
ZA200207002B (en) 2004-03-31
PT1267899E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
DE60112413D1 (de) Ssa inaktivierte salmonella impfstoffe
NO20031483L (no) Vaksine
NO20030823L (no) Vaksiner
NO20024172D0 (no) Vaksine
NO20031705L (no) Vaksiner
NO20014325L (no) Vaksine
DE60135542D1 (de) Echanischem verschluss
NO20021433D0 (no) Vaksiner
DK1343525T3 (da) Forbedret Mycoplasma hyopneumonia bacterinvaccine
NO20006191D0 (no) Vaksine
DK1427444T3 (da) West-nil-vaccine
DK1265633T3 (da) Vaccineadjuvans
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20033882D0 (no) Vaksine
NO20020763D0 (no) Vaksine
NO20030239L (no) Modifisert virus
IS5694A (is) Bóluefni
FI20002454A (fi) Lämmönsiirrin
DK1194450T3 (da) Inaktiveret vaccine imod felin calicivirose
DE50105483D1 (de) Feuerstätte
FI20002648A0 (fi) Lämmönsiirrin
ATA11732000A (de) Heizkessel
ITBA20010050A0 (it) Arpione
PL374051A1 (en) Salmonella vaccine
FI20010903A (fi) Lämmityskattila

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee